Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production

Journal of Lipid Research

Volumn 31, Issue 4, 1990, Pages 567-582

  Arad, Y ^a   Ramakrishnan, R ^a   Ginsberg, H N ^a  

^a College of Physicians/Surgeons ^*  (United States)

Author keywords

fractional catabolic rate; HMG CoA reductase; IDL; Kinetic modeling; VLDL

Indexed keywords

APOLIPOPROTEIN B; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MEVINOLIN; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CLINICAL ARTICLE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEINS B; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, LDL CHOLESTEROL; LIPOPROTEINS, VLDL; LOVASTATIN; MALE; MIDDLE AGE; SUPPORT, U.S. GOV'T, P.H.S.; TRIGLYCERIDES;

EID: 0025345666     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)